Prevalence of detection and dynamics of selection and reversion of K65R mutation in nucleoside reverse transcriptase inhibitor-experienced patients failing an antiretroviral regimen
- PMID: 15905744
Item in Clipboard
Prevalence of detection and dynamics of selection and reversion of K65R mutation in nucleoside reverse transcriptase inhibitor-experienced patients failing an antiretroviral regimen
J Acquir Immune Defic Syndr.
.
No abstract available
Similar articles
-
Evaluating the role of etravirine in the second-line antiretroviral therapy after failing an initial non-nucleoside reverse transcriptase inhibitor-based regimen in a resource-limited setting.Curr HIV Res. 2008 Sep;6(5):474-6. doi: 10.2174/157016208785861230. Curr HIV Res. 2008. PMID: 18855659
-
Patterns of resistance emerging in HIV-1 from antiretroviral-experienced patients undergoing intensification therapy with tenofovir disoproxil fumarate.J Acquir Immune Defic Syndr. 2004 Nov 1;37(3):1340-50. doi: 10.1097/00126334-200411010-00002. J Acquir Immune Defic Syndr. 2004. PMID: 15483463 Clinical Trial.
-
Comparative selection of the K65R and M184V/I mutations in human immunodeficiency virus type 1-infected patients enrolled in a trial of first-line triple-nucleoside analog therapy (Tonus IMEA 021).J Virol. 2005 Aug;79(15):9572-8. doi: 10.1128/JVI.79.15.9572-9578.2005. J Virol. 2005. PMID: 16014919 Free PMC article. Clinical Trial.
-
Options for a second-line antiretroviral regimen for HIV type 1-infected patients whose initial regimen of a fixed-dose combination of stavudine, lamivudine, and nevirapine fails.Clin Infect Dis. 2007 Feb 1;44(3):447-52. doi: 10.1086/510745. Epub 2006 Dec 27. Clin Infect Dis. 2007. PMID: 17205457
-
Identification of a rare mutation at reverse transcriptase Lys65 (K65E) in HIV-1-infected patients failing on nucleos(t)ide reverse transcriptase inhibitors.J Antimicrob Chemother. 2013 Oct;68(10):2199-204. doi: 10.1093/jac/dkt200. Epub 2013 Jun 7. J Antimicrob Chemother. 2013. PMID: 23749955
Cited by
-
Modeling dynamic interactions between pre-exposure prophylaxis interventions & treatment programs: predicting HIV transmission & resistance.Sci Rep. 2011;1:185. doi: 10.1038/srep00185. Epub 2011 Dec 7. Sci Rep. 2011. PMID: 22355700 Free PMC article.
-
Transmitted Drug Resistance Among Human Immunodeficiency Virus (HIV)-1 Diagnoses in the United States, 2014-2018.Clin Infect Dis. 2022 Mar 23;74(6):1055-1062. doi: 10.1093/cid/ciab583. Clin Infect Dis. 2022. PMID: 34175948 Free PMC article.
-
HIV, transmitted drug resistance, and the paradox of preexposure prophylaxis.Proc Natl Acad Sci U S A. 2010 Jul 6;107(27):12381-6. doi: 10.1073/pnas.1006061107. Epub 2010 Jun 28. Proc Natl Acad Sci U S A. 2010. PMID: 20616092 Free PMC article.
-
The K65R mutation in human immunodeficiency virus type 1 reverse transcriptase exhibits bidirectional phenotypic antagonism with thymidine analog mutations.J Virol. 2006 May;80(10):4971-7. doi: 10.1128/JVI.80.10.4971-4977.2006. J Virol. 2006. PMID: 16641288 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
